UMeWorld reported Q2 FY2026 results on May 14 and disclosed two distinct moves on the sustainable aviation fuel side: Project Verdant, the company’s SAF initiative, has completed process engineering design for the Phase I pretreatment unit (PTU), and the single-cell-oil (SCO) feedstock initiative, producing renewable lipids by microbial fermentation of waste biomass, is being positioned as the long-term anchor for SAF carbon intensity. The company named global SAF markets including Europe as the target on CI grounds.
SCO is a lipid — chemically a triglyceride-rich oil produced by microbial fermentation — so it feeds INTO the HEFA pathway rather than around it. What SCO changes is the upstream substrate base: instead of drawing from the existing waste-lipid pool (used cooking oil, tallow, distillers corn oil), an SCO route grows the lipid on cellulosic or other waste-biomass substrates via fermentation. That matters because HEFA’s binding constraint between now and 2030 is lipid feedstock availability, with used cooking oil already split between aviation, road diesel and chemicals. If SCO commercializes at acceptable yield and cost, it expands the addressable HEFA feedstock pool without competing for UCO. The carbon-intensity argument matters specifically for export markets: ReFuelEU Aviation does not price lifecycle CI directly but the underlying RED III sustainability criteria gate which feedstocks qualify, and CORSIA Eligible Fuel status is awarded at the finished-fuel level through approved sustainability certification schemes such as RSB CORSIA or ISCC CORSIA.
Q2 represents an important inflection point for the Company. We are beginning to see our distribution platform translate into accelerating commercial activity, increasing product movement, and broader market engagement, while at the same time advancing our long-term SAF strategy.
The framing, from CEO Michael Lee, pairs near-term consumer wellness revenue with a long-cycle SAF play through the DAGola® functional nutrition brand on one side and Project Verdant on the other. On the SAF side, Phase I pretreatment unit process engineering design is complete and the company says discussions are advancing with potential technology licensors, EPC contractors and technical advisory firms. The named SAF pathway is HEFA. SCO is the feedstock layer that, if it commercializes, would feed into that HEFA pathway as an alternative to lipid-pool sourcing.
Financial scale remains small and that is the relevant comparison set when reading the SCO claim. Q2 FY2026 revenue was $351,187, up 138 percent from Q1’s $147,455; gross profit was $15,152 versus $4,692; net loss narrowed to $105,450 from $145,230; inventory drew down from approximately $1.68 million at December 31 2025 to approximately $1.37 million at March 31 2026. UMeWorld is a company still in early commercial scale-up on the nutrition side and pre-FID on the SAF side. SCO is also not unique to UMeWorld; comparable single-cell-oil work has been underway at developers in the United States and Europe for several years and the commercial-scale economics remain unproven.
Project Verdant has cleared a pretreatment engineering milestone, which is upstream of EPC commitment, financial close, and CORSIA or ICAO sustainability certification. Worth watching: which technology licensor lands the Project Verdant HEFA license, whether UMeWorld’s SCO process moves out of pilot into demonstration scale, and whether the company can finance the next phase given the current revenue base.
